News > Private Equity > Exits
SPE Capital exits Orchidia
Word count: 503
SPE Capital, formerly Swicorp Private Equity, has agreed to exit its investment in Orchidia Pharmaceutical Industries, an Egyptian ophthalmic generic medicine manufacturer.
Purchase access: $0
* New users receive access to two premium articles for FREE; Click here to find out how